Related Experiment Videos
Mechanisms of reperfusion injury
1Department of Physiology, University of Tennessee-Memphis Health Science Center.
Abstract:
Reperfusion of ischemic organs can result in tissue injury that is manifested as microvascular and parenchymal cell dysfunction. Reactive oxygen metabolites and polymorphonuclear leukocytes (PMN) have been implicated in the pathobiology of reperfusion injury. Reactive oxygen metabolites mediate the lipid peroxidation detected in postischemic tissues and promote the formation of inflammatory agents that recruit and activate PMN. These PMN appear to inflict reperfusion-induced tissue injury. Drugs that scavenge or inhibit the formation of reactive oxygen metabolites and/or prevent the recruitment of PMN may be useful in the treatment of reperfusion injury.
Insights
Reperfusion injury causes cell dysfunction via reactive oxygen metabolites and white blood cells (PMN). Therapies targeting these factors may treat this condition.
Area of Science:
- Biomedical Science
- Pathophysiology
- Cellular Biology
Background:
- Reperfusion of ischemic organs can cause significant tissue injury.
- This injury involves microvascular and parenchymal cell dysfunction.
- Reactive oxygen metabolites and polymorphonuclear leukocytes (PMN) are key players in reperfusion injury.
Purpose of the Study:
- To elucidate the role of reactive oxygen metabolites and PMN in reperfusion injury.
- To identify potential therapeutic targets for mitigating reperfusion-induced tissue damage.
Main Methods:
- The study reviews the pathobiology of reperfusion injury.
- It highlights the involvement of reactive oxygen metabolites in lipid peroxidation and inflammation.
- It discusses the role of PMN in inflicting tissue damage during reperfusion.
Main Results:
- Reactive oxygen metabolites mediate lipid peroxidation in postischemic tissues.
- These metabolites promote inflammation, recruiting and activating PMN.
- Activated PMN contribute to reperfusion-induced tissue injury.
Conclusions:
- Reactive oxygen metabolites and PMN are critical mediators of reperfusion injury.
- Therapeutic strategies aimed at scavenging reactive oxygen metabolites or inhibiting PMN recruitment may be beneficial.
- Developing drugs to target these pathways could offer effective treatment for reperfusion injury.